Table 3.
Univariate analysis and multivariate analysis for predictors of advanced fibrosis in the elderly and non-elderly patients with NAFLD
| Characteristics | Elderly NAFLD patients | Non-elderly NAFLD patients | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| OR (95%CI) | P-value | OR (95%CI) | P-value | OR (95%CI) | P-value | OR (95%CI) | P-value | |
| Age > 70 years | 2.22 (0.85–5.80) | 0.103 | 2.24 (0.43–11.61) | 0.338 | ||||
| Female | 2.60 (1.33–5.08) | 0.005 | 3.21 (1.37–7.54) | 0.007 | 0.89 (0.53–1.47) | 0.639 | 0.59 (0.3–1.15) | 0.119 |
| BMI > 25 kg/m2 | 2.74 (1.25–6.00) | 0.011 | 2.41 (0.85–6.8) | 0.098 | 1.13 (0.55–2.31) | 0.741 | 0.94 (0.35–2.54) | 0.904 |
| Central obesity | 4.75 (1.34–16.88) | 0.016 | 4.09 (0.68–24.67) | 0.124 | 1.24 (0.53–2.88) | 0.62 | 1.18 (0.44–3.18) | 0.747 |
| Diabetes mellitus | 2.07 (1.00–4.26) | 0.049 | 2.29 (0.88–5.93) | 0.088 | 3.88 (2.22–6.79) | < 0.001 | 3.38 (1.7–6.73) | 0.001 |
| Hypertension | 3.73 (1.53–9.07) | 0.004 | 3.68 (1.11–12.23) | 0.034 | 1.29 (0.76–2.21) | 0.346 | 1.59 (0.8–3.12 | 0.183 |
| Dyslipidemia | 1.36 (0.56–3.33) | 0.494 | 1.01 (0.58–1.76) | 0.97 | ||||
| Platelet count < 140 × 109/L | 2.73 (1.12–6.67) | 0.027 | 2.43 (0.59–9.91) | 0.217 | 4.06 (1.85–8.88) | < 0.001 | 4.18 (1.32–13.25) | 0.015 |
OR odd ratios, CI confidence intervals